One River Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$87K Sell
3,100
-264,100
-99% -$7.03M 0.03% 228
2025
Q4
$6.65M Buy
267,200
+196,600
+278% +$4.96M 0.63% 24
2025
Q3
$1.8M Buy
70,600
+69,894
+9,900% +$1.73M 0.49% 51
2025
Q2
$54.5K Sell
706
-69,894
-99% -$1.63M 0.12% 42
2025
Q1
$1.79M Buy
+70,600
New +$1.85M 0.28% 52
2024
Q4
Sell
-11,500
Closed -$333K 316
2024
Q3
$333K Buy
+11,500
New +$335K 0.04% 172

Other funds holding PFE

One River Asset Management's PFE Position: Q1 2026 in Review

One River Asset Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 24,450 shares — an estimated $651K sold.

One River Asset Management first reported a position in PFE in Q1 2025 and held it in 4 quarters. The position peaked at $609K in Q4 2025. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • One River Asset Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • One River Asset Management sold 24,450 Pfizer shares in Q1 2026, an estimated $651K.
  • One River Asset Management first reported a position in Pfizer in Q1 2025 and held it in 4 quarters.
  • One River Asset Management's Pfizer position peaked at $609K in Q4 2025.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on One River Asset Management's 13F filing for Q1 2026, filed 27 Apr 2026.